2014-11-17T17:27:50-06:00 2014-03-31 KPMG LLP 345 Park Avenue New York NY 101540102 990 2013-04-01 131949477 NEW YORK BLOOD CENTER INC % C ELIZABETH GIBSON NEWY 2125703100 310 EAST 67TH STREET Suite NEW YORK NY 10065 ELIZABETH C GIBSON SENIOR VICE PRESIDENT & CFO 2125703100 2014-11-17 true KPMG LLP P01249521 2125703100 2014-11-16 2013 2015-11-30 17:44:51Z DR CHRISTOPHER HILLYER 310 EAST 67TH STREET NEW YORK NY 10065 407263669 false X nybloodcenter.org X 1959 NY As one of the most preeminent and comprehensive blood centers in the world, NYBC operates under a four- part mission. For more information, see Sch. O and Part III, 4a-c. 18 17 1424 228 -662605 -716990 8973000 10720155 300205000 298860345 14445000 8108120 5667000 2585134 329290000 320273754 338321 283844 0 0 111345000 109909092 0 67000 328485 216011679 210351077 327695000 320611013 1595000 -337259 459201000 471298905 71807000 71108584 387394000 400190321 X As one of the most preeminent and comprehensive blood centers in the world, NYBC operates under a four-part mission. For more information, see Sch. O and Part III, 4a-c. false false 140071028 260579 156641757 BLOOD SERVICES: THE COLLECTION AND PROCESSING OF BLOOD PRODUCTS, AND THE DISTRIBUTION OF THESE PRODUCTS TO HOSPITALS IN THE GREATER NY AREA FOR TRANSFUSIONS TO PATIENTS. 135136865 141982021 MEDICAL PROGRAMS: PROGRAMS INCLUDE (1) CLINICAL SERVICES (INCLUDING TRANSFUSION THERAPY SERVICES); (2) BONE MARROW PROGRAM; AND (3) HEMOPHILIA SERVICES CONSORTIUM. NATIONAL CORD BLOOD PROGRAM: THE COLLECTION, PROCESSING AND STORAGE OF CORD BLOOD UNITS AND THE DISTRIBUTION OF THESE UNITS FOR TREATMENT OR FOR RESEARCH PURPOSES. 14599272 23265 236567 RESEARCH PROGRAM: THE NEW YORK BLOOD CENTER OPERATES A WIDE-RANGING PROGRAM OF RESEARCH INTO THE PROPERTIES OF BLOOD AND BLOOD RELATED DISEASES. 289807165 true true false true false false false false false false true true false false true true true false false true true false false true true false false true true true false false false false false false false false true false false false false false false false false true 80 0 1424 true true true true LI false false false true true false false false false false false false X 18 17 true false true false false false false true true false false true true true true true true true true false CT NJ NY OK X C ELIZABETH GIBSON 2125703016 310 EAST 67TH STREET NEW YORK NY 10065 X HOWARD P MILSTEIN CHAIRMAN, BOARD OF TRUSTEES 7.5 X X 0 0 0 ANDREW BODNAR MD JD CHAIRMAN, EXECUTIVE COMMITTEE 5.0 X 0 0 0 DAVID TENDLER VICE-CHAIR, BOARD OF TRUSTEES 5.0 X X 0 0 0 HARRIET EDELMAN TRUSTEE 2.0 X 0 0 0 OWEN GARRICK MD TRUSTEE 1.0 X 0 0 0 WILLIAM W CROUSE TRUSTEE 2.0 X 0 0 0 JOHN MULLEN TRUSTEE 2.0 X 0 0 0 MICHAEL W HODIN PHD TRUSTEE 2.0 X 0 0 0 AARON R MARCU TRUSTEE 2.0 X 0 0 0 HOWARD SLOAN TRUSTEE 1.0 X 0 0 0 ROBERT A SCHWARTZ TRUSTEE 2.0 X 0 0 0 CHRISTOPHER HILLYER PRESIDENT & CEO 50.0 X X 1227158 0 43707 MARC KRAMER TRUSTEE 1.0 X 0 0 0 JOHN ZUCCOTTI TRUSTEE 1.0 X 0 0 0 NICHOLAS SCOPPETTA TRUSTEE 1.0 X 0 0 0 MICHELLE MIAO TRUSTEE 1.0 X 0 0 0 LAURIE H GLIMCHER MD TRUSTEE 1.0 X 0 0 0 JENNIFER JONES AUSTIN TRUSTEE 1.0 X 0 0 0 ELIZABETH MCQUAIL SVP-CHIEF OPERATING OFFICER 50.0 X 416037 0 48977 EVA QUINLEY SVP-QUALITY& REGULATORY AFFAIR 50.0 X 273471 0 27964 BETH SHAZ SVP-CHIEF MEDICAL OFFICER 50.0 X 390599 0 41969 JORDANA SCHWARTZ VP-GENRL COUNSEL & SECR 50.0 X 358795 0 31100 C ELIZABETH GIBSON SVP-CHIEF FINANCIAL OFFICER 50.0 X 415054 0 42945 BETSY JETT VP - QUALITY AND REG AFFAIRS 50.0 X 0 0 0 MICHAEL MONAHAN VP-CHIEF ADMIN OFFICER 50.0 X 360562 0 35402 MICHELE SCAGGIANTE CHIEF INFORMATION OFFICER 50.0 X 262389 0 41945 MOHANDAS NARLA VP-RESEARCH PROGRAMS 50.0 X 366798 0 33567 PABLO RUBINSTEIN VP-NATIONAL CORD BLOOD PROGRAM 50.0 X 367413 0 33327 CONNIE WESTHOFF DIR-IMMUNOHEMATOLOGY & MEMBER 50.0 X 272135 0 32534 ROBERT PURVIS VP-CUSTOMER SERVICE 50.0 X 256745 0 40445 HARVEY SCHAFFLER EXEC DIR- DONOR MARKETING 50.0 X 233865 0 46421 5201021 0 500303 133 false true false Creative Testing Solutions PO Box 29871 PHOENIX AZ 850389871 Blood Testing 19456630 ATOS IT SOLUTIONS PO BOX 710878 COLUMBUS OH 432710878 IT OUTSOURCE 2980558 INTEGRA CONTRACTING 1550 STILWELL AVENUE BRONX NY 10461 CONSTRUCTION 1661178 DONOR DIALOGUE 300 E BIG BEAVER RD SUITE 400 TROY MI 40483 Telemarketing 1376485 CENTURY PROTECTIVE SERVICES 600 N BROADWAY SUITE 208 WHITE PLAINS NY 10603 Guard Services 886486 38 1090158 7732735 1897262 143407 10720155 BLOOD SERVICES 621500 156641757 156641757 RESEARCH PROGRAM 541700 236567 236567 MEDICAL PROGRAMS 621500 141982021 141982021 298860345 6486096 -662605 7148701 0 2751718 2751718 250615 250615 0 250615 250615 87893000 191000 86072148 389828 1820852 -198828 1622024 1622024 110740 1090158 527939 -417199 0 -417199 0 0 0 320273754 298860345 -662605 11355859 105690 105690 178154 178154 0 0 5174151 5174151 0 77743095 72840281 4776838 125976 4237586 3813827 423759 16973414 14679328 2275241 18845 5780846 5226473 550000 4373 203427 203427 2275702 2275702 418007 418007 76966 76966 67000 67000 1207967 1207967 1305803 964517 264399 76887 52843 6179 46664 1771722 1678054 93668 3770541 3770541 196419 196419 4166181 3838360 327821 185481 141305 44176 0 0 1274050 1274050 0 10950241 8469832 2480409 2348759 2128445 220314 SUPPLIES 121024257 120963890 60367 TESTING FEES 18674192 18674192 MGMT FEE-HEMOPHILA CONSORTIUM 11564723 11564723 REPAIRS, MAINT & EQUIPMENT 5994431 4699231 1295200 22889365 18287249 4566712 35404 320611013 289807165 30475363 328485 2355000 1105247 38642000 21477795 0 0 40147000 47880579 0 0 0 0 0 0 43697000 45676808 2612000 2998630 163799301 108196861 59976000 55602440 204304000 218925139 65759000 74485671 0 0 0 3146596 1709000 0 459201000 471298905 42129000 43107362 0 0 181000 2228352 0 0 0 0 0 0 22803000 20713024 0 0 6694000 5059846 71807000 71108584 X 386267000 398594890 1127000 1595431 0 0 387394000 400190321 459201000 471298905 X -337259 11526000 1607580 X false true X true true true X 12012000 12414000 13569000 8973000 10720155 57688155 343218000 325505000 308061000 300205000 298860345 1575849345 0 0 0 355230000 337919000 321630000 309178000 309580500 1633537500 129965 112550 268518 214413 85000 810446 0 129965 112550 268518 214413 85000 810446 1632727054 20730000 10358000 14338000 20112000 9488429 75026429 194602 19621 214223 20730000 10552602 14357621 20112000 9488429 75240652 0 0 375960000 348471602 335987621 329290000 319068929 1708778152 0.95549 0.96645 0.04403 0.03306 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 76966 76966 321258834 321335800 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 37315 42045 78043 76966 234369 250000 250000 250000 250000 1000000 1500000 0 2118174 2118174 0 34432696 31130043 3302653 0 38973913 6833424 32140489 0 48942498 41003542 7938956 0 39332020 29229852 10102168 55602440 PRIVATE INVESTMENT FUNDS 24017942 F HEDGE FUNDS 50467729 F 74485671 0 RESERVE FOR CLAIMS 1000000 FMV OF INTEREST RATE SWAP AGRE 4059846 5059846 X 334406000 11526000 272933 2333313 14132246 320273754 320273754 321610000 272933 726054 998987 320611013 320611013 SCHEDULE D, PART X, LINE 2 NYBC HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE A NOT-FOR-PROFIT CORPORATION, EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). AS A NOT-FOR-PROFIT CORPORATION, NYBC IS ALSO EXEMPT FROM STATE AND LOCAL INCOME TAXES. NYBC RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO NYBC'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. NYBC DID NOT RECOGNIZE ANY UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED MARCH 31, 2014 AND 2013. PART XI, LINE 2D UNREALIZED GAIN ON SWAP AGREEMENT $1,634,000 RECLASS OF SPECIAL EVENT EXPENSES 528,172 RECLASS OF NET LOSS FROM SALE OF PP&E 198,828 CONTRIBUTION REFUND (27,997) Rounding 310 --------- TOTAL $2,333,313 ========= PART XII, LINE 2D RECLASS OF SPECIAL EVENT EXPENSES $528,172 RECLASS OF NET LOSS FROM SALE OF PP&E 198,828 Rounding (946) ------- Total $726,054 ======= Sub-Saharan Africa 1 28 Program Services CHIMPANZEE SANCTUARY 380440 Central America and the Caribbean Investments 3520537 Central America and the Caribbean Investments 5654092 1 28 1 28 9555069 9555069 true false true true true false ACTIVITIES OUTSIDE U.S. SCHEDULE F, PART I, LINE 3F AMOUNT REFLECTED ARE PROGRAM SERVICES EXPENDITURES ONLY, REPORTED ON AN ACCRUAL BASIS. X true CMI EVENTS CATHY MCNAMARA BIANNUAL DINNER false 1090000 67000 1023000 1090000 67000 1023000 CT NJ NY BIANNUAL DINNER 1200898 1090158 110740 215662 312277 0 1200898 1090158 110740 215662 312277 527939 -417199 true GALIEN FOUNDATION 60 BROAD STREET NEW YORK NY 10004 264549935 501(c)(3) 7000 CHARITABLE CONTRIBUTION AMERICAN ASSN OF BLOOD BANKS 8101 GLENBROOK RD BETHESDA MD 20814 362384118 501(c)(3) 75000 CHARITABLE CONTRIBUTION NY ACADEMY OF MEDICINE 145 WEST 45 ST STE 300 NEW YORK NY 10036 131656674 501(c)(3) 6000 CHARITABLE CONTRIBUTION 3 COLLEGE SCHOLARSHIPS 223 178154 PART I, LINE 2 NYBC HAS PROVIDED FINANCIAL ASSISTANCE, RATHER THAN GRANTS, TO THE ORGANIZATIONS LISTED IN PART I. THIS ASSISTANCE IS CONSISTENT WITH NYBC'S CHARITABLE MISSION. PART III, LINE 1 COLLEGE SCHOLARSHIPS AWARDED TO STUDENTS WHO VOLUNTEER THEIR TIME AT BLOOD DRIVES IN THE FURTHERANCE OF NYBC'S MISSION. X X X X X false false false false false false false false false ELIZABETH MCQUAIL SVP-CHIEF OPERATING OFFICER 416037 0 0 0 0 0 25500 0 25061 0 466598 0 0 0 MOHANDAS NARLA VP-RESEARCH PROGRAMS 366798 0 0 0 0 0 17850 0 17300 0 401948 0 0 0 PABLO RUBINSTEIN VP-NATIONAL CORD BLOOD PROGRAM 340541 0 0 0 26872 0 25500 0 9411 0 402324 0 0 0 CHRISTOPHER HILLYER PRESIDENT & CEO 945758 0 250000 0 31400 0 17850 0 27441 0 1272449 0 0 0 EVA QUINLEY SVP-QUALITY& REGULATORY AFFAIR 258948 0 0 0 14523 0 17850 0 11900 0 303221 0 0 0 BETH SHAZ SVP-CHIEF MEDICAL OFFICER 390599 0 0 0 0 0 17850 0 25703 0 434152 0 0 0 JORDANA SCHWARTZ VP-GENRL COUNSEL & SECR 358795 0 0 0 0 0 17850 0 14834 0 391479 0 0 0 MICHAEL MONAHAN VP-CHIEF ADMIN OFFICER 360562 0 0 0 0 0 17850 0 18892 0 397304 0 0 0 MICHELE SCAGGIANTE CHIEF INFORMATION OFFICER 262389 0 0 0 0 0 17850 0 26757 0 306996 0 0 0 CONNIE WESTHOFF DIR-IMMUNOHEMATOLOGY & MEMBER 272135 0 0 0 0 0 17850 0 16128 0 306113 0 0 0 C ELIZABETH GIBSON SVP-CHIEF FINANCIAL OFFICER 415054 0 0 0 0 0 17850 0 26679 0 459583 0 0 0 ROBERT PURVIS VP-CUSTOMER SERVICE 256745 0 0 0 0 0 17850 0 23969 0 298564 0 0 0 HARVEY SCHAFFLER EXEC DIR- DONOR MARKETING 233865 0 0 0 0 0 23505 0 24153 0 281523 0 0 0 X 1 1200 fmv X TICKETS 2 142207 Estimated Value false false false PART I, LINE 31 NYBC IS CURRENTLY REVISING ITS GIFT ACCEPTANCE POLICY TO INCLUDE SPECIFIC LANGUAGE REGARDING THE REVIEW OF NON-STANDARD CONTRIBUTIONS. MISSION STATEMENT PART I, LINE 1 AND PART III, LINE 1 AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NEW YORK BLOOD CENTER OPERATES UNDER A FOUR-PART MISSION. SPECIFICALLY, NYBC EXISTS: -TO PROVIDE THE HIGHEST QUALITY BLOOD AND STEM CELL PRODUCTS AND RELATED MEDICAL AND CONSULTATIVE SERVICES TO HOSPITALS AND PATIENTS PRIMARILY IN THE GREATER NEW YORK METROPOLITAN AREA -TO CONDUCT THE HIGHEST QUALITY, NOVEL AND INNOVATIVE RESEARCH IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING AND TRANSFUSION MEDICINE, AND CELLULAR THERAPIES, THUS ADVANCING THESE FIELDS AND POSITIVELY IMPACTING THE PUBLIC HEALTH -TO DEVELOP PRODUCTS, TECHNOLOGIES, AND SERVICES IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING, AND TRANSFUSION MEDICINE AND CELLULAR THERAPIES, WITH THE POTENTIAL TO HAVE WORLDWIDE HUMANITARIAN IMPACT -TO TRAIN THE NEXT GENERATION OF LEADERS IN EACH OF THESE FIELDS SIGNIFICANT CHANGE TO ORGANIZATIONAL DOCUMENTS PART VI, SECTION A, LINE 4 CHANGES WERE MADE TO THE ORGANIZATION'S CERTIFICATE OF INCORPORATION, AMENDING THE GEOGRAPHICAL TERRITORY OF ITS ACTIVITIES AND ADDING LANGUAGE REGARDING ITS SCIENTIFIC STUDY AND RESEARCH IN THE AREAS OF REGENERATIVE MEDICINE AND CELLULAR THERAPY. PROCESS OF FORM 990 REVIEW BY GOVERNING BODY Part VI, Line 11A Following completion of the financial audit, the Form 990 is finalized by management, reviewed by an independent accounting firm, and reviewed and approved by the Audit Committee of the Board. The final Form 990 is then circulated to the full Board for review and approval at its annual meeting. COMPLIANCE WITH CONFLICT OF INTEREST POLICY Part VI, Line 12c At the beginning of each new fiscal year, and on an as-needed basis, the taxpayer requires all trustees, officers, key employees, and senior executives to complete and sign a statement disclosing any actual or apparent conflict of interest. The Board will determine whether any conflict of interest exists and, if so, it appoints a disinterested person or committee to investigate and determine how to manage any such conflict. In addition, the taxpayer maintains a general conflict of interest policy that applies to all employees. PROCESSES FOR DETERMINING COMPENSATION Part VI, Line 15 THE TAXPAYER'S PROCESS FOR DETERMINING COMPENSATION OF ITS CEO INCLUDED REVIEW AND APPROVAL BY THE INDEPENDENT COMPENSATION AND EXECUTIVE COMMITTEES OF THE BOARD AND BY THE FULL BOARD, AS WELL AS ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, AND FORMS 990 OF OTHER ORGANIZATIONS. ALL COMPENSATION REVIEW PROCESSES ARE CONTEMPORANEOUSLY DOCUMENTED. FOR DETERMINING COMPENSATION OF ITS OTHER OFFICERS AND ITS KEY EMPLOYEES, THE TAXPAYER HAS USED HISTORICAL ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, REVIEW BY THE CEO AND APPROVAL BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. PUBLIC AVAILABILITY OF INFORMATION Part VI, Line 19 The taxpayer makes its financial statements available upon request, and its governing documents, Conflict of Interest Policy and Code of Conduct available both upon request and on its website. OTHER CHANGES IN NET ASSETS Part XI, LINE 9 Unrealized Gain on swap agreement $1,634,000 Contribution Refund (27,997) Rounding 1,577 --------- Total $1,607,580 ========= GOVERNING BODY PART VI, SECTION A 1A THE BOARD MAY DESIGNATE STANDING COMMITTEES FROM AMONG ITS MEMBERS. THESE COMMITTEES INCLUDE AN EXECUTIVE COMMITTEE, COMPRISED OF A CHAIR, VICE CHAIR, AND AT LEAST THREE ADDITIONAL MEMBERS OF THE BOARD. THE EXECUTIVE COMMITTEE MAY EXERCISE BOARD POWERS IN BETWEEN MEETINGS OF THE BOARD. OFFICER, DIRECTOR, TRUSTEE, OR KEY EMPLOYEE BUSINESS RELATIONSHIP PART VI, SECTION A, LINE 2 HARRIET EDELMAN, HOWARD MILSTEIN, JOHN ZUCCOTTI, MICHAEL HODIN: BUSINESS RELATIONSHIP